Blog
RSS FeedPosted by Michael Wonder on 04 May 2026
'Tearing her skin apart': Sydney family among thousands priced out of life-changing medication
3 May 2026 - Jade Hlucshniow was on the brink of selling her home to afford treatment for her daughter, ...
Posted by Michael Wonder on 03 May 2026
Affordable treatment for Australians with colorectal cancer
3 May 2026 - Australians with stage 4 colorectal cancer are among those who will benefit from new drug listings ...
Posted by Michael Wonder on 01 May 2026
Agenda for the May 2026 PBAC meeting
1 May 2026 - The agenda for the May 2026 PBAC meeting is now available. ...
Posted by Michael Wonder on 30 Apr 2026
Schedule of Pharmaceutical Benefits - 1 May 2026
1 May 2026 - The May 2026 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Apr 2026
Have your say on the framework for consumer engagement in HTA
29 April 2026 - We are developing a framework that sets out guiding principles, focus areas and actions to support ...
Posted by Michael Wonder on 30 Apr 2026
Draft 2026-27 Cost Recovery Implementation Statement for listing medicines on the PBS and designated vaccines on the NIP
30 April 2026 - Consultation on the draft 2026-27 Cost Recovery Implementation Statement (CRIS) for listing medicines on the Pharmaceutical ...
Posted by Michael Wonder on 28 Apr 2026
Broken PBS system behind failure to list Mounjaro for type 2 diabetics, according to Medicines Australia
28 April 2026 - Hundreds of thousands of Australians with diabetes will continue paying thousands of dollars a year for ...
Posted by Michael Wonder on 27 Apr 2026
Price feud over Mounjaro denies Australians access to cheaper diabetes and weight loss drug
24 April 2026 - Hundreds of thousands of Australians with type 2 diabetes mellitus could miss out on access to ...
Posted by Michael Wonder on 25 Apr 2026
‘Unviable’: 450,000 Australians to miss out on subsidised weight loss drug
24 April 2026 - An estimated 450,000 Australians will miss out on discounted weight loss medication after pharmaceutical giant Eli ...
Posted by Michael Wonder on 25 Apr 2026
Drug company Lilly refuses to list Mounjaro on PBS, says price too low
24 April 2026 - Drug company Eli Lilly has refused to place Mounjaro on the PBS despite the regulator recommending ...
Posted by Michael Wonder on 25 Apr 2026
‘Diffficult to see’ Mounjaro funded for weight loss, says pharma as diabetes stoush erupts
25 April 2026 - The weight loss drug has finally been recommended for public funding for those with diabetes, but manufacturers ...
Posted by Michael Wonder on 25 Apr 2026
Public summary documents – December 2025 PBAC meeting
24 April 2026 - The Public summary documents from the December 2025 PBAC meeting are now available. ...
Posted by Michael Wonder on 25 Apr 2026
Recommendations made by the PBAC – March 2026
24 April 2026 - Recommendations made by the PBAC in March 2026 relating to the listing of medicines on the ...
Posted by Michael Wonder on 22 Apr 2026
Southern NSW family's push for affordable eczema medication so kids can have a normal childhood
22 April 2026 - Playing rugby league with his friends is one of Tanner Hosie's favourite things to do, but ...
Posted by Michael Wonder on 21 Apr 2026
PBS reform critical to accessing medical breakthroughs
20 April 2026 - We are witnessing an extraordinary medical revolution. Advances that once belonged in science fiction, like regenerative ...